Labpro INC

Labpro INC was paid $3.19M by Medicaid between Jan 2018 and Feb 2020, across 105 billing codes. Its largest line is G0480, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed — 38% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Illinois

Rank by total paid#51 of 235

Median peer was paid$123K

This provider vs. median26×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	183,270	$2.17M
2019	48,256	$1.02M
2020	83	$0.00

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	38%	20,508	10,932	$1.22M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	30%	28,118	15,155	$951K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	8.2%	7,309	4,433	$263K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	3.3%	3,941	2,760	$106K
80321		2.2%	5,187	3,131	$69K
80370		2.0%	1,616	1,149	$63K
80348		1.1%	9,013	6,244	$34K
80373		<1%	7,101	4,918	$32K
80361		<1%	11,425	8,379	$29K
80355		<1%	3,733	3,034	$23K
80337		<1%	439	247	$21K
80324		<1%	8,182	5,539	$20K

93 more codes

80368		<1%	755	$20K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	581	$19K
80366		<1%	3,271	$18K
80346		<1%	8,465	$17K
80354		<1%	7,924	$17K
80353		<1%	7,923	$17K
80358		<1%	7,069	$16K
80338		<1%	1,389	$14K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	2,823	$13K
80356		<1%	10,960	$13K
80344		<1%	596	$12K
80365		<1%	8,910	$12K
80372		<1%	2,555	$11K
84443	Thyroid stimulating hormone (TSH)	<1%	2,373	$9K
80360		<1%	6,398	$9K
82607		<1%	1,958	$8K
80345		<1%	5,361	$8K
82746		<1%	1,763	$7K
80050	General health panel	<1%	776	$7K
80061	Lipid panel	<1%	2,946	$7K
80053	Comprehensive metabolic panel	<1%	3,049	$7K
80359		<1%	3,396	$6K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	63	$6K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	144	$5K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	144	$5K
83550		<1%	1,751	$5K
83036	Hemoglobin; glycosylated (A1C)	<1%	2,462	$5K
80362		<1%	2,590	$5K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	3,072	$5K
80369		<1%	2,008	$4K
80349		<1%	1,973	$4K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	155	$4K
84480		<1%	1,200	$4K
83540		<1%	1,391	$4K
86141		<1%	213	$3K
84436		<1%	625	$3K
86038		<1%	940	$2K
84439		<1%	1,378	$2K
85651		<1%	1,355	$2K
84479		<1%	407	$2K
84550		<1%	1,333	$2K
82728		<1%	429	$2K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	46	$2K
82533		<1%	131	$2K
83695		<1%	193	$2K
87086	Culture, bacterial; quantitative colony count, urine	<1%	344	$1K
83735		<1%	265	$1K
87481		<1%	53	$1K
82150		<1%	910	$1K
82550		<1%	222	$1K
86703		<1%	154	$949.96
86140		<1%	912	$933.03
86696		<1%	41	$720.21
81003		<1%	713	$658.05
84153		<1%	264	$631.39
36415	Collection of venous blood by venipuncture	<1%	2,061	$538.29
86695		<1%	41	$537.30
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	54	$520.35
82043		<1%	143	$418.29
86694		<1%	39	$410.56
83718		<1%	130	$323.52
86803		<1%	279	$258.83
84703		<1%	164	$253.24
86592		<1%	64	$235.58
84460		<1%	152	$230.78
84075		<1%	152	$223.72
84450		<1%	152	$223.72
83992		<1%	26	$220.00
84478		<1%	130	$218.61
82310		<1%	153	$214.18
82374		<1%	152	$213.43
81001		<1%	146	$211.15
82247		<1%	152	$209.98
84295		<1%	152	$207.98
82565		<1%	169	$205.58
84132		<1%	158	$204.65
82040		<1%	151	$203.70
82435		<1%	152	$200.15
85610		<1%	78	$190.15
82977		<1%	45	$189.85
82465		<1%	130	$170.94
82947		<1%	154	$165.32
84520		<1%	148	$162.32
84155		<1%	152	$160.10
87340		<1%	19	$151.02
80048	Basic metabolic panel (calcium, ionized)	<1%	55	$134.68
84702		<1%	19	$97.83
80074		<1%	18	$88.76
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	30	$50.22
80177		<1%	13	$36.94
88142		<1%	12	$31.98
80076		<1%	33	$8.69
80371		0%	37	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLATINIK, ELLIOTT (PRESIDENT)